Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.

Medicare enrollees will now pay a maximum of $2,000 on out-of-pocket prescription drug costs annually as part of another provision of the Inflation Reduction Act. The limit applies to prescription drugs bought at pharmacies and through mail orders, which are covered through Medicare Part D.

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual out-of-pocket spending on prescription drugs to $2,000 for Medicare

Senior citizen enrolled in Medicare Part D prescription coverage will now have out-of-pocket drug costs capped at $2,000 a year.The new benefit that went into e

The provision was implemented to help lower prescription drug costs for Medicare users. Saquon Barkley and family react to Eagles sitting him with chance to break NFL rushing record What Is the Shower Curtain Effect and How Do I Stop It?

With the start of 2025, Medicare beneficiaries will benefit from a new $2,000 cap on out-of-pocket prescription drug costs, a significant change aimed at easing